Bharat Biotech

BharatBiotech's tweets receive a high number of likes and retweets, indicating strong public interest in their content. Their engagement is largely driven by vaccine-related announcements and responses to media scrutiny.

The audience primarily consists of individuals interested in biotechnology, healthcare, and vaccine development. They are likely to include professionals, researchers, and the general public seeking updates on vaccine safety and availability.

The account frequently highlights the safety and efficacy of COVAXIN® through data and trial results. They actively address misinformation and media reports, emphasizing transparency and ethical standards. Their content is focused on promoting their vaccines and positioning themselves as a leader in pandemic response.